APIDRA (insulin glulisine) Patient Assistance Program
Don’t let the high cost of brand rapid-acting insulin disrupt your diabetes management. We help eligible patients access Apidra (insulin glulisine) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Apidra (insulin glulisine) is FDA-approved to improve glycemic control in adults and pediatric patients (≥4 years) with diabetes mellitus. It is a rapid-acting mealtime (bolus) insulin analog with onset within 15 minutes, peak at 1–2 hours, and duration ~3–4 hours.
- Without assistance, brand Apidra costs commonly run approximately $250–$330 per 10 mL vial or per 5-pen pack of SoloStar prefilled pens.
- Through AffordMyPrescriptions, qualifying patients can access Apidra for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- An authorized generic of insulin glulisine (under the generic name insulin glulisine) is now available at substantially lower cost. Other rapid-acting mealtime insulins include insulin lispro (Humalog and its biosimilar Admelog and authorized generic), insulin aspart (NovoLog and biosimilars Fiasp/Truvelog), and the federal $35/month Medicare insulin cap for Part D beneficiaries makes most insulins much more affordable.
What Is Apidra Prescription Assistance Program?
The Apidra Prescription Assistance Program is a manufacturer-sponsored initiative that provides Apidra at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for diabetes patients requiring rapid-acting insulin who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, endocrinology/primary care coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and renewal.
Pharmacy Price Comparison
- Without assistance, brand Apidra costs roughly $250–$330 per vial or pen pack. Authorized generic insulin glulisine is cheaper, and Medicare patients now have a $35/month insulin cap. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$320 | Save ~$250/mo |
| CVS Pharmacy (brand) | ~$330 | Save ~$260/mo |
| Walmart (brand) | ~$270 | Save ~$200/mo |
| Costco (brand) | ~$255 | Save ~$185/mo |
Authorized generic | ~$100 | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Apidra Prescription Program?
The Patient Assistance Program is free to apply for and provides Apidra at no medication cost if approved. Our $69.95/month service covers full advocacy. With Medicare Part D’s $35/month insulin cap and authorized generic insulin glulisine widely available, we’ll help you and your provider determine the most affordable path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Apidra:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $700–$900/dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Apidra assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Apidra Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Apidra:
Apidra (insulin glulisine) is a rapid-acting mealtime (bolus) insulin analog. It is biochemically modified human insulin designed for faster absorption and shorter duration than regular human insulin — making it ideal for mealtime dosing to control post-meal blood glucose elevation.
How Apidra Works:
Dietary carbohydrates raise blood glucose after eating, which normally prompts the pancreas to release a rapid burst of insulin to prevent hyperglycemia. In diabetes, this natural response is impaired or absent, requiring mealtime insulin coverage. Insulin glulisine is a modified human insulin designed to prevent hexamer formation, allowing for more rapid absorption from subcutaneous tissue. This results in an onset within 15 minutes, a peak at 1–2 hours, and a duration of about 3–4 hours to mimic natural mealtime insulin.
Form and use:
Apidra is administered as a subcutaneous injection either 15 minutes before or immediately after a meal, with doses individualized based on blood glucose and carbohydrate intake. It is available in 10 mL vials and 3 mL SoloStar prefilled pens, and injection sites like the abdomen, thigh, upper arm, or buttock must be rotated. This insulin can also be used in insulin pumps and is compatible for mixing with NPH, though not with most other insulins.
Generic availability:
An authorized generic version of insulin glulisine is available at a substantially lower cost than brand-name Apidra. Other similar rapid-acting mealtime insulins include insulin lispro (Humalog, Admelog) and insulin aspart (NovoLog), which share similar onset, peak, and duration profiles. For financial accessibility, Medicare Part D caps insulin copays at $35 per month for its beneficiaries.
Warnings:
The most common adverse effect of Apidra is hypoglycemia, requiring blood glucose monitoring and a ready source of rapid-acting glucose. It also carries warnings for hypokalemia due to potassium shifting into cells, severe allergic reactions, and fluid retention or heart failure when combined with thiazolidinediones. Additionally, changing physical activity, illness, or meals can alter insulin requirements, and pump malfunctions can risk hyperglycemia or DKA.
FAQ (Frequently Asked Questions)
How Much Does Apidra Cost Without Insurance?
Brand Apidra costs approximately $250–$330 per vial or pen pack. Authorized generic insulin glulisine is dramatically cheaper. Medicare Part D beneficiaries now pay $35/month maximum for covered insulin. Through AffordMyPrescriptions, qualifying patients receive Apidra at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Is The Authorized Generic The Same As Brand Apidra?
Yes. An authorized generic is the brand product manufactured by the same company, sold under a generic name at lower cost. Authorized generic insulin glulisine has the same active ingredient at the same concentration as brand Apidra. Most insurance plans cover the authorized generic at lower copay than brand.
How Is Apidra Different From Humalog Or NovoLog?
All three are rapid-acting mealtime insulin analogs with similar onset (15 min), peak (1–2 hours), and duration (3–4 hours). The choice between Apidra (insulin glulisine), Humalog (insulin lispro), and NovoLog (insulin aspart) often depends on insurance coverage and personal preference. Most patients have similar glycemic control with any of these. Newer ultra-rapid insulins (Fiasp, Lyumjev) have slightly faster absorption.
What About The Medicare $35 Insulin Cap?
Effective January 1, 2023, Medicare Part D capped patient out-of-pocket cost at $35/month per covered insulin product. This applies to all insulin formulations covered by Part D — making most insulins (including Apidra) much more affordable for Medicare beneficiaries. Some Medicare Advantage and commercial plans also offer $35/month insulin caps; ask your plan.
When Should I Inject Apidra Relative To Meals?
Typically 15 minutes before a meal — this aligns insulin onset with meal-induced glucose absorption for optimal post-meal glucose control. In some situations (uncertain food intake, gastroparesis, young children), immediate post-meal injection may be preferred. Discuss timing with your diabetes care team.
Can I Use Apidra In An Insulin Pump?
Yes. Apidra is FDA-approved for use in external insulin pumps. The infusion set should be changed every 48 hours per current guidelines. Watch for pump malfunction signs (high unexplained glucose), which can quickly lead to hyperglycemia and ketoacidosis since pumps deliver only rapid-acting insulin.
What If My Application Is Denied?
If denied, we explore alternatives — switching to authorized generic insulin glulisine, authorized generic insulin lispro (often the cheapest mealtime insulin option), the manufacturer’s commercial copay program, Medicare $35/month cap if applicable, or independent foundations such as the American Diabetes Association, JDRF, or PAN Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Apidra, our team may be able to help you access assistance programs — or guide you to authorized generic insulin glulisine, the Medicare $35/month cap, or another affordable mealtime insulin. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.